Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia | Data + Perspectives: Clinical Investigators Discuss the Role of CAR T-Cell Therapy for Patients with Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

Featuring perspectives from Dr Joshua Brody, Dr Matthew Lunning and Dr Jason Westin, moderated by Dr Lunning, including the following topics:

Introduction (0:00)

Integration of Chimeric Antigen Receptor (CAR) T-Cell Therapy into the Management of Diffuse Large B-Cell Lymphoma — Dr Westin (1:34)

Current Role of CAR T-Cell Therapy for Other B-Cell Lymphomas — Dr Lunning (21:17)

Tolerability and Other Practical Considerations with CAR T-Cell Therapy — Dr Brody (40:15)

CME information and select publications

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.